Katharina Lindner

6PUBLICATIONS
31CO-AUTHORS
NanomedicineImmunogenetics (incl. genetic immunology)Molecular targetsTumour immunologyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Aug 03, 2026
Author Correction: IDH1-mutant vaccine in newly diagnosed astrocytoma: final analysis of the multicenter, single-arm, open-label, first-in-human phase 1 NOA16 trial.

|Jul 01, 2026
IDH1-mutant vaccine in newly diagnosed astrocytoma: final analysis of the multicenter, single-arm, open-label, first-in-human phase 1 NOA16 trial.

|Mar 07, 2024
Prediction of tumor-reactive T cell receptors from scRNA-seq data for personalized T cell therapy.

C L Tan, K Lindner, T Boschert

|Feb 02, 2024
H3K27M neoepitope vaccination in diffuse midline glioma induces B and T cell responses across diverse HLA loci of a recovered patient.

Tamara Boschert, Kristina Kromer, Taga Lerner

|Sep 22, 2023
A H3K27M-targeted vaccine in adults with diffuse midline glioma.

Niklas Grassl, Isabel Poschke, Katharina Lindner

|Apr 19, 2020
The Outcome of Ex Vivo TIL Expansion Is Highly Influenced by Spatial Heterogeneity of the Tumor T-Cell Repertoire and Differences in Intrinsic In Vitro Growth Capacity between T-Cell Clones.

Isabel C Poschke, Jessica C Hassel, Aaron Rodriguez-Ehrenfried

Pageof 1

Frequent Collaborators

5 joint publications

Lukas Bunse

5 joint publications

Michael Platten

4 joint publications

Isabel Poschke

3 joint publications

Wolfgang Wick